335 related articles for article (PubMed ID: 9857183)
1. A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor.
Izumi Y; Hirata M; Hasuwa H; Iwamoto R; Umata T; Miyado K; Tamai Y; Kurisaki T; Sehara-Fujisawa A; Ohno S; Mekada E
EMBO J; 1998 Dec; 17(24):7260-72. PubMed ID: 9857183
[TBL] [Abstract][Full Text] [Related]
2. Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life.
Weskamp G; Cai H; Brodie TA; Higashyama S; Manova K; Ludwig T; Blobel CP
Mol Cell Biol; 2002 Mar; 22(5):1537-44. PubMed ID: 11839819
[TBL] [Abstract][Full Text] [Related]
3. PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor.
Mori S; Tanaka M; Nanba D; Nishiwaki E; Ishiguro H; Higashiyama S; Matsuura N
J Biol Chem; 2003 Nov; 278(46):46029-34. PubMed ID: 12952982
[TBL] [Abstract][Full Text] [Related]
4. Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme.
Merlos-Suárez A; Ruiz-Paz S; Baselga J; Arribas J
J Biol Chem; 2001 Dec; 276(51):48510-7. PubMed ID: 11600492
[TBL] [Abstract][Full Text] [Related]
5. Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity.
Roghani M; Becherer JD; Moss ML; Atherton RE; Erdjument-Bromage H; Arribas J; Blackburn RK; Weskamp G; Tempst P; Blobel CP
J Biol Chem; 1999 Feb; 274(6):3531-40. PubMed ID: 9920899
[TBL] [Abstract][Full Text] [Related]
6. Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta.
Nelson KK; Schlöndorff J; Blobel CP
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):673-80. PubMed ID: 10527948
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1.
Howard L; Nelson KK; Maciewicz RA; Blobel CP
J Biol Chem; 1999 Oct; 274(44):31693-9. PubMed ID: 10531379
[TBL] [Abstract][Full Text] [Related]
8. Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein.
Koike H; Tomioka S; Sorimachi H; Saido TC; Maruyama K; Okuyama A; Fujisawa-Sehara A; Ohno S; Suzuki K; Ishiura S
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):371-5. PubMed ID: 10510302
[TBL] [Abstract][Full Text] [Related]
9. Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C.
Dethlefsen SM; Raab G; Moses MA; Adam RM; Klagsbrun M; Freeman MR
J Cell Biochem; 1998 May; 69(2):143-53. PubMed ID: 9548562
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.
Sahin U; Weskamp G; Kelly K; Zhou HM; Higashiyama S; Peschon J; Hartmann D; Saftig P; Blobel CP
J Cell Biol; 2004 Mar; 164(5):769-79. PubMed ID: 14993236
[TBL] [Abstract][Full Text] [Related]
11. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity.
Goishi K; Higashiyama S; Klagsbrun M; Nakano N; Umata T; Ishikawa M; Mekada E; Taniguchi N
Mol Biol Cell; 1995 Aug; 6(8):967-80. PubMed ID: 7579712
[TBL] [Abstract][Full Text] [Related]
12. PKCα and PKCδ regulate ADAM17-mediated ectodomain shedding of heparin binding-EGF through separate pathways.
Kveiborg M; Instrell R; Rowlands C; Howell M; Parker PJ
PLoS One; 2011 Feb; 6(2):e17168. PubMed ID: 21386996
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic analysis of Meltrin alpha (ADAM12)-deficient mice: involvement of Meltrin alpha in adipogenesis and myogenesis.
Kurisaki T; Masuda A; Sudo K; Sakagami J; Higashiyama S; Matsuda Y; Nagabukuro A; Tsuji A; Nabeshima Y; Asano M; Iwakura Y; Sehara-Fujisawa A
Mol Cell Biol; 2003 Jan; 23(1):55-61. PubMed ID: 12482960
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic domain phosphorylation of heparin-binding EGF-like growth factor.
Wang X; Mizushima H; Adachi S; Ohishi M; Iwamoto R; Mekada E
Cell Struct Funct; 2006; 31(1):15-27. PubMed ID: 16557002
[TBL] [Abstract][Full Text] [Related]
15. The stress- and inflammatory cytokine-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor is mediated by p38 MAPK, distinct from the 12-O-tetradecanoylphorbol-13-acetate- and lysophosphatidic acid-induced signaling cascades.
Takenobu H; Yamazaki A; Hirata M; Umata T; Mekada E
J Biol Chem; 2003 May; 278(19):17255-62. PubMed ID: 12611888
[TBL] [Abstract][Full Text] [Related]
16. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.
Hinkle CL; Sunnarborg SW; Loiselle D; Parker CE; Stevenson M; Russell WE; Lee DC
J Biol Chem; 2004 Jun; 279(23):24179-88. PubMed ID: 15066986
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism for activation of heparin-binding EGF-like growth factor induced by stimuli].
Umata T
J UOEH; 2004 Mar; 26(1):85-97. PubMed ID: 15038074
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor (EGF) ligand release by substrate-specific a disintegrin and metalloproteases (ADAMs) involves different protein kinase C (PKC) isoenzymes depending on the stimulus.
Dang M; Dubbin K; D'Aiello A; Hartmann M; Lodish H; Herrlich A
J Biol Chem; 2011 May; 286(20):17704-13. PubMed ID: 21454702
[TBL] [Abstract][Full Text] [Related]
19. The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading.
Gechtman Z; Alonso JL; Raab G; Ingber DE; Klagsbrun M
J Biol Chem; 1999 Oct; 274(40):28828-35. PubMed ID: 10497257
[TBL] [Abstract][Full Text] [Related]
20. Ectodomain shedding of HB-EGF: a potential target for cancer therapy.
Miyazono K
J Biochem; 2012 Jan; 151(1):1-3. PubMed ID: 21976708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
